Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

95.07
-0.0300-0.03%
Post-market: 95.070.00000.00%19:30 EDT
Volume:18.13K
Turnover:1.72M
Market Cap:412.60M
PE:53.01
High:95.58
Open:95.58
Low:94.62
Close:95.10
52wk High:98.82
52wk Low:70.01
Shares:4.34M
Float Shares:4.34M
Volume Ratio:1.42
T/O Rate:0.42%
Dividend:1.33
Dividend Rate:1.40%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.67
PE(LYR):5.10

Loading ...

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Dow Jones
·
Sep 15

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
Sep 15

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Sep 14

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Sep 14

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Sep 14

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Sep 14

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Sep 14

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Sep 12

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
Sep 12

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11